Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 7/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | JAK2 | O60674 | 1/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | CTSG | P08311 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29354172 | 0.91 | MPO (0.56) | DHFRCYP2D6PIK3CGALDH1A1MEN1 | |
| SCHEMBL29355325 | 0.77 | NPC1 (0.43) | DHFRCYP2D6PIK3CGMEN1MAPT | |
| SCHEMBL4847314 | 0.74 | DHFR (0.69) | DHFRCYP2D6 | |
| SCHEMBL17802559 | 0.74 | DHFR (0.53) | DHFRCYP2D6 | |
| SCHEMBL8903271 | 0.72 | CYP2D6 (0.78) | DHFRCYP2D6 | |
| SCHEMBL6429787 | 0.71 | CYP2D6 (0.71) | DHFRCYP2D6 | |
| SCHEMBL6347041 | 0.71 | DHFR (0.74) | DHFRCYP2D6 | |
| SCHEMBL6342295 | 0.71 | DHFR (0.60) | DHFRCYP2D6 | |
| SCHEMBL3746280 | 0.70 | PIK3CG (1.00) | DHFRCYP2D6PIK3CGALDH1A1MEN1 | |
| SCHEMBL27084609 | 0.70 | CYP2D6 (0.75) | DHFRCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119470614-A | Strong and weak magnetism automatic scanning monitor of metal composite defect | 辽宁石油化工大学 | 2025-02-18 | — | — | CN | claimed |
| US-20240251654-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2024-07-25 | — | — | US | claimed |
| CN-115561175-A | Device and method for judging existence and volume of medium by using optical signal | 北京莱伯泰科仪器股份有限公司 | 2023-01-03 | — | — | CN | claimed |
| EP-4741409-A1 | FUSED-RING CARBAZOLE TETRADENTATE METAL PLATINUM (II) COMPLEX AND USE THEREOF, AND ELECTRONIC DEVICE | Zhejiang University of Technology (CN) | 2026-05-13 | — | — | EP | disclosed |
| CN-222816186-U | Fire extinguishing device for lithium battery detection | 武汉蔚澜新能源科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-12282021-B2 | Stratification of acute myeloid leukaemia patients for sensitivity to kinase pathway inhibitor therapy | KINOMICA LIMITED (GB) | 2025-04-22 | — | — | US | disclosed |
| US-20250057913-A1 | USE OF SOMATOSTATIN AGONIST IN THE TREATMENT OF SSTR3 EXPRESSING TUMORS | ITALFARMACO SPA (IT) | 2025-02-20 | — | — | US | disclosed |
| CN-119470614-A | Strong and weak magnetism automatic scanning monitor of metal composite defect | 辽宁石油化工大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119431459-A | Tetracoordinate carbazole tetradentate metal platinum (II) complex, electronic device and application thereof | 浙江工业大学 | 2025-02-14 | — | — | CN | disclosed |
| CN-118425873-B | Phenotype detection circuit and method for electric energy meter | 武汉盛帆电子股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2025025447-A1 | FUSED-RING CARBAZOLE TETRADENTATE METAL PLATINUM (II) COMPLEX AND USE THEREOF, AND ELECTRONIC DEVICE | 浙江工业大学 | 2025-02-06 | — | — | WO | disclosed |
| CN-117342278-B | Protective plate conveying device for building construction | 中国建筑第五工程局有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-117342278-A | Protective plate conveying device for building construction | 中国建筑第五工程局有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-107866448-B | Centering control system | 中色科技股份有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-107866447-B | Centering deviation rectifying control system | 中色科技股份有限公司 | 2023-07-14 | — | — | CN | disclosed |
| WO-2023118437-A1 | USE OF SOMATOSTATIN AGONIST IN THE TREATMENT OF SSTR3 EXPRESSING TUMORS | ITALFARMACO S.P.A. (IT) | 2023-06-29 | — | — | WO | disclosed |
| US-11667514-B2 | Quantitative essential oil dripping device | SHENZHEN DITUO ELECTRONIC CO., LTD. (CN) | 2023-06-06 | — | — | US | disclosed |
| CN-115561175-A | Device and method for judging existence and volume of medium by using optical signal | 北京莱伯泰科仪器股份有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-114407036-A | Cluster robot and charging equipment thereof | 国科温州研究院(温州生物材料与工程研究所) | 2022-04-29 | — | — | CN | disclosed |
| US-11230599-B2 | Tumor mutational load | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057913-A1 | USE OF SOMATOSTATIN AGONIST IN THE TREATMENT OF SSTR3 EXPRESSING TUMORS | SSTR3, SSTR1, SSTR5 | DHFR 4734/4885CYP2D6 3331/4885PIK3CG 1478/4885 |
| US-20240251654-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | LEF1, EFNA1, EML4 | DHFR 2630/4885CYP2D6 2300/4885PIK3CG 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.